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Thyroid nodules occur frequently, are more
common in women, and the incidence increases with
age for both sexes. Clinically normal thyroid glands
commonly contain nodules in autopsy series. In
20- to 50-year-old females, as high as 50% of the
thyroid glands are nodular, whereas in males the
incidence approaches 30% (I). When the prevalence of clinically palpable thyroid nodules was the
objective of the Framingham population researchers,
Vander et al (2) detected nodules in 6.4% of females
and 1.5% of males aged 30-50 years. Even with
diligent, thorough examination of the neck, only
about one tenth of pathologically nodular thyroid
glands can be detected. However, the number of
palpable nodules is significant, and determination of
the pathology of the nodule or goiter, once found,
rests with the patient's physician. Unfortunately, a
detailed history and physical examination frequently
does not provide all the necessary information
needed to make a definite etiologic or pathologic
diagnosis. Knowledge of the type of goiter is mandatory for proper treatment of the various disorders
of the thyroid gland.
The various types or causes of goiters are shown
in Table l. Goiters may be divided clinically into
diffuse or nodular; hyperthyroid, euthyroid, or
hypothyroid. It is readily apparent that several
pathologic entities may be diffuse or nodular in addition to altering thyroid function . Hyperthyroid
patients may have a diffuse goiter, solitary nodule, or
a multinodular gland. Graves' disease usually presents no diagnostic problems, but, rarely, a toxic

* Presented by Dr. Fratkin at the Postgraduate Course in
Nuclear Medicine, February 27, 1975, in Williamsburg, Virginia.
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diffuse goiter may be caused by excessive pituitary
thyroid-stimulating hormone (TSH) from hypothalamic thyrotropin-releasing hormone (TRH)
stimulation or pituitary tumor. Subacute nonsuppurative thyroiditis may be focal or diffuse and cause
transitory hyperthyroidism. The hyperthyroid phase
of this disease is associated with a low or blocked
radioactive iodine uptake (RAIU) and usually a painful, hard gland. The hyperthyroid adenomatous
goiter produces the usual findings of thyrotoxicosis
and, clinically, a multinodular goiter. Evaluation of a
toxic adenoma will be discussed later.
Euthyroid diffuse goiters, with the exception of
thyroiditis, represent compensatory enlargement of
the gland in an attempt to maintain normal hormone
production. Patients with dietary iodine deficiency
have an elevated RAIU that is suppressible with
supraphysiologic doses of thyroid hormone (our
standard procedure is to give l 50µg daily of
triiodothyronine for seven days). E'xcessive iodine intake is associated with a suppressed or blocked
RAIU . Diffuse goiter from congenital thyroidal enzyme deficiency, that is, peroxidase deficiency, results
in an initially elevated RAIU with discharge of
radioiodine from the gland following potassium
perchlorate administration. The early adenomatous
goiter often feels diffuse rather than nodular. The
RAI U usually is normal, but the scan often shows
nonuniform distribution of radioactivity within the
gland. Subacute thyroiditis may diffusely involve the
gland, and the patient may be euthyroid when seen.
Chronic thyroiditis (Hashimoto's thyroiditis) is a
painless, firm goiter frequently with high titers of antithyroid antibodies present in the serum. Any of the
diffuse goiters may be accompanied by hypothyroidism, but low thyroid function is more comMCV QUARTER LY 11 (2): 78-83, 1975
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TABLE I
Types of Goiters
DIFFUSE

NODULAR
HYPERTHYROID

Graves' Disease
Excess TSH
Thyroiditis

Adenomatous
Adenoma
Thyroiditis
EUTHYROID

Iodine Deficiency
Iodine Excess
,Enzymatic Defects*
Adenomatous
Thyroiditis*

<:arcinoma
Aden om a
Colloid Cyst
Adenomatous
Thyroiditis

* May be associated with hypothyroidism

manly seen with congenital enzymatic deficiency
goiters and Hashimoto's thyroiditis.
Patients with nodular goiter ( as mentioned
earlier) may be hyperthyroid or, rarely, hypothyroid,
but are usually euthyroid. The euthyroid patients
with nodular goiter, and especially those with a
solitary nodule, represent the greatest diagnostic
problem, for thyroid carcinoma must always be considered and excluded. Since one cannot differentiate a
benign from a malignant tumor with certainty by
palpation alone, further diagnostic tests are indicated
(Fig. 1). The thyroid scan will determine whether the
nodule is functioning (Fig. 2) or nonfunctioning (Fig.
3). The pathology of functioning (hot) and nonfunctioning (cold) nodules is shown in Table 2. The
demonstration of a hot nodule with scanning essentially excludes the probability that the lesion is a carcinoma. However, if the nodule is cold, one can only
make a statistical guess concerning the pathology.
Further diagnostic work-up can be pursued prior to
surgical exploration (Fig. 1). Nonfunctioning,
solitary nodules may be separated into cystic and
solid with ultrasonography, and recent reports (3, 4)
suggest that cystic thyroid nodules represent 20% of
cold nodules and are benign. Additional procedures
have been performed in an attempt to non-invasively
exclude thyroid carcinoma. Sonography (5), in addition to distinguishing cystic from solid lesions,
demonstrates a characteristic echo pattern in
malignancy that may prove to be diagnostic if substantiated by additional reports. Thyroid scanning of
cold nodules with other radiopharmaceuticals such as
67 Ga-citrate (6) and 75 Selenomethionine (7, 8) ·m ay be
positive in cases of thyroid cancer, but false negatives
( 67 Ga) and
false positives {7 5 Se) are frequent.
Thermography (9) has been tried, but the number

of lesions studied are too few to reach any conclusions. According to an oral communication
from J. Frable, MD, in January, 1975, thin-bore needle aspiration can yield a positive diagnosis of papiflary adenocarcinoma, but cannot differentiate follicular adenoma from adenocarcinoma. I might sum
up by saying that the solitary, nonfunctioning and especially the solid thyroid nodule is malignant until
proven otherwise by surgical exploration, The results
of sonography are exciting and promising, but
further studies are indicated before the role of
ultrasound can be established in the evaluation of
thyroid nodules (Fig. 4).
The thyroid nodule that concentrates radioiodine may be a follicular adenoma, adenomatous
nodule, normal thyroid tissue such as a lingual thyroid, or residual hyperplastic thyroid tissue following
a subtotal thyroidectomy. The triiodothyronine suppression test will differentiate the autonomously functioning thyroid nodule from other types of functioning nodules (Fig. 5). Treatment of suppressible
functioning thyroid nodules with thyroid hormone
results usually in no further enlargement and frequently in disappearance clinically of the nodule.
The typical autonomously functioning thyroid
nodule is illustrated in Figure 2. Although the patient
is euthyroid, the nodule has suppressed the function
of the normal thyroid tissue and is not suppressible
with administration of triiodothyronine (Cytomel®).
Administration of thyroid-stimulating hormone, 10
units daily for three days, may be used to
demonstrate the presence of normal but suppressed
thyroid tissue. Treatment with 25 millicuries of
radioactive iodine resulted in ablation of the nodule,
appearance of the previously suppressed normal
thyroid gland, and continuation of a euthyroid state.
EVALU ATION OF THY ROID N ODU LES
DI AG N O STI C APPRO ACH
THYRO ID N ODULE

FUNCTIONl t..JG
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NON-FUNCTIONI NG
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SOLI D

CYSTI C

Fig. I-Sequential diagnostic approach in evaluation of thyroid
nodules.
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Fig. 2-Left. Functioning 4 X 3 cm right thyroid nodule with normal RAIU and serum free thyroxine concentration; no radioiodine
uptake in area of left lobe. Center. Triiodothyronine (T-3) administration produced no decrease in RAIU or nodule uptake. Right.
Following radioiodine treatment, nodule has been ablated; right and left lobes concentrate radioiodine; overall thyroid function remains
normal.

..

The question arises, though, should a nontoxic,
autonomously functioning nodule be treated at all?
What is the natural history of a functioning follicular
adenoma? There are case reports of nontoxic nodules
progressing to toxic nodules which then require
treatment because of the development of clinical
hyperthyroidism . Such a course of events is shown
in Figure 6. Patient W.W. first noted a goiter 15 years
ago, but was advised that no treatment was necessary.
In 1969, his protein-bound iodine (PBI) was normal ,
and his nodule had gradually increased in size.
When seen in 1973, he was hyperthyroid. Treatment
with radioiodine achieved a euthyroid state but little
to no reduction in the size of the nodule. It can be
assumed that he had an autonomously functioning
nodule from the onset that progressed in size over the
years, achieving a sufficient mass to produce excessive amounts of thyroid hormone and hyperthyroidism .
TABLE 2
Pathology of Thyroid Nodules

.
Fig. 3-Nonfunctioning thyroid nodule in lower pole of right
lobe. Pathologic di agnosis was follicular adenoma.

HISTOLOGIC DIAGNOSIS

FUNCTIONING NONFUNCTIONING
No. PERCENT No . PERCENT

Adenomatous
Adenoma
Carcinoma
Hyperplasia
Thyroiditis, Chronic
Unclassified
Total

53
11
0
5
0
_§
75

70
15
0
7
0
8

107
31

24
0
7

-1.2.
184

58
17
13
0

4
8
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EVALUATION OF THYROID NODULES
APPROACH TO TREATMENT

EVALUATION OF THYROID NODULES
APPROACH TO TREATMENT
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*FURTHER EVALUATION OF NON-FUNCTIONING, SOLID
THYROID NODULE IS INVESTIGATIONAL (1975)

Fig. 4-Role of sonography in therapeutic approach to nonfunctioning thyroid nodules.

Is this case the exception or the rule? Horst and
associates ( 10) and later Ferraz et al (11) suggest that
the natural history of a nontoxic but autonomously
functioning thyroid nodule is one of progression to
hyperthyroidism. They based their conclusions on
data demonstrating toxic nodules being larger than
nontoxic ones, and the rather continuous spectrum of
functional activity from euthyroidism to overt
hyperthyroidism. Similarly, Hamburger and Meier
(12) noted that those patients who were hyperthyroid

RAIU-5hr.-23% .
F~e_e ! .:!!- 6.~_~g_f.dl

TOXIC

NON-TOXIC
Rx: 131 I

Rx: 1311

SURGERY
OBSERVATION
Fig. 5-Diagnostic and therapeutic approach to functioning
thyroid nodule.

were older and had larger nodules than euthyroid
patients with nonsuppressible functioning nodules. In
their prospective study of 28 nontoxic patients with
autonomously functioning nodules followed one to
ten years (majority followed less than six years), none
became hyperthyroid, but four glands increased in
size. A retrospective study by McCormack and
Sheline ( 13) revealed 1 out of 14 nontoxic untreated
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Fig. 6-Left. Large 9 X 6 cm toxic nodule with high RAIU and serum free thyroxine concentration. Right. Establishment of normal
function, but persistence of nodule following radioiodine treatment.
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Fig. 7-Left. Functioning thyroid nodule in lower right lobe with partial suppression of the remainder of the gland. Right. Loss of function
in outlined nodule.

patients developed hyperthyroidism. The longest
follow-up was 8 \/2 years with a mean of about 4 years.
The available data suggest circumstantially that nontoxic, autonomously functioning thyroid nodules
progress to toxicity, but usually not within the first
eight to ten years from the initial diagnosis.
The next case (Fig. 7) illustrates the opposite
natural history-spontaneous disappearance of function from a hot nodule. The initial scan shows a functioning nodule with partial suppression of the
remaining gland. Treatment with triiodothyronine,
l 50µg daily for seven days, resulted in a RAIU of I%,
and no specific therapy was instituted. The patient
became concerned about the small but visible mass in
her neck. When she returned nine months later, the
nodule had lost its ability to take up radioiodine.
Surgical exploration revealed a follicular adenoma.
Our experience and that of others (10, 13) reveal

that large doses of radioiodine (20-40 millicuries) are
necessary to ablate autonomously functioning
thyroid nodules, that euthyroid function is achieved,
and that hypothyroidism does not develop following
treatment when the normal thyroid tissue is protected
by endogenous and/ or exogenous thyroid hormone.
On occasion, a residual but nonfunctioning nodule
may persist following radioiodine therapy. Surgery,
although equally effective therapy (13), adds unnecessary additional cost and morbidity for the patient
with an autonomously functioning thyroid nodule.
In summary, functioning but suppressible
thyroid nodules may be treated successfully with
thyroid hormone (Fig. 5). Completely or partially
autonomously functioning nodules are benign follicular adenomas. This type of nodule may progress
in size to produce hyperthyroidism or may lose its
ability to concentrate iodine. Radioiodine is a safe,
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efficient treatment for autonomously functioning
thyroid nodules and should be considered the treatment of choice.
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